United States: EPO Practice - Priority Pitfalls In European Patent Applications Based On U.S. Priority Applications

Article 87 of the European Patent Convention (EPC) allows applicants for European patent applications to claim the benefit of the filing date ("priority date") of an earlier application ("priority application") under certain conditions.  While Article 87 EPC broadly corresponds to Article 4 of the Paris Convention, the European Patent Office's (EPO) implementation of Article 87 EPC can lead to denial of priority claims and, ultimately, loss of applicant's rights.  Without careful attention by practitioners, claiming the benefit of a U.S. priority application may result in loss of rights. 

The EPO Enlarged Board of Appeal (EBA) specifically considered the interpretation of Article 87 EPC in its decision G2/98.  The following key points arise when claiming priority under Article 87 EPC:

  1. The European application must be for the same invention as the priority application, and  
  2. The priority application must be the first application for protection of the invention and must not be filed more than twelve months before the European application's filing date. 

Although the EPO does not routinely examine priority claims, to avoid the risks of improperly claiming priority—and detrimentally relying on invalid priority claims—practitioners should carefully assess the contents of the priority application and European application before filing to ensure the claimed priority is valid.1  Further, during prosecution of the European application, practitioners should cautiously amend the European claims to maintain the valid priority claim.  Scenarios exemplifying some common priority pitfalls are discussed below. 

Priority Claims to the "Same Invention"

According to the EBA in G2/98, the EPO acknowledges priority claims for the "same invention" "only if the skilled person can derive the subject-matter of the claim directly and unambiguously, using common general knowledge, from the previous application as a whole."2  Thus, the EPO priority standard requires not only that all elements of a claim be explicitly or implicitly disclosed in the priority application, but that any claimed combination also be so disclosed.  This standard is the same applied to determine the validity of added subject matter by amendment under Article 123(2) EPC.3  Simply stated, if a claim could not be added to a priority application without contravening Article 123(2) EPC, it cannot validly claim the priority date. 

  1. Claiming Priority to a U.S. Provisional Application Filed Without Claims

U.S. provisional applications can be filed without claims, and in some cases with as little as a single drawing.  Although these applications qualify as potential bases for priority under Article 87(3) EPC, they routinely fail to provide valid priority dates for claims generalizing their specifically disclosed features.  Even the EPO's "whole contents" approach in Article 88(4) EPC, which recognizes that priority may be granted for subject matter disclosed but not claimed in the priority application, offers scant assistance in establishing priority.

Indeed, EPO practice under Article 123(2) EPC routinely denies broadening amendments such as attempts to define a range based only on a series of discrete values or introducing generalized terms from discrete example (e.g., broadening "diesel engine" to "combustion engine").  Without any claims or statements corresponding to claims in the priority application, the claims added to the European application often cannot be clearly and unambiguously derived from the priority application. 

  1. Claiming Priority to a U.S. Provisional or Nonprovisional Application Filed with Very Broad Claims

Including only very broad claims in a priority application does not guarantee the priority of narrower claims falling within their scope.  A priority application that recites, for example, a range or a genus does not necessarily support narrower claims presented in the European application because the range or genus claim in the provisional application cannot be separated into a narrower subgenus or species without supporting direct and unambiguous disclosure in the application as filed.4

  1. Claiming Priority to a U.S. Provisional or Nonprovisional Application Filed with Very Narrow Claims

The analogous case involving only narrow claims can have similar problems.  Although the specific claims and examples may be sufficient to support a broader claim, without the unambiguous disclosure of the broader claim scope, no valid priority may be claimed.    

As seen in each of the three preceding scenarios, either the lack of corresponding claims or the lack of disclosure providing direct and unambiguous derivation of the claim scope can be fatal to a priority claim in a later European application.  When filing an application that is to serve as a basis for priority, practitioners must consider providing a proper basis for later claims at the EPO. 

Practitioners may avoid the traps in the preceding scenarios by incorporating language that closely resembles future claim language in a claimless provisional application, including alternative embodiments and definitions of subgenus and species falling within the scope of broad claims, and unambiguously disclosing broader claim scope in priority applications with narrow claims.   

Priority Claims to the "First Application"
European applications claiming priority to U.S. continuation-in-part (CIP) applications raise unique questions of priority under Article 87(1) EPC regarding the "first application" for protection of the claimed invention.  Because CIP disclosures include content from an earlier parent application and later new matter, valid priority claims turn on whether the European application claims relate only to the new matter in the CIP.5  The critical point when analyzing the validity of a CIP priority claim is to determine if the CIP is the first application to disclose the invention claimed in the European application.6 

  1. Support for the European Application Claims Only Found in a CIP

A European application properly claims priority to a CIP where the European application claims relate solely to new matter contained in the CIP (i.e., cannot be derived from the parent application).  The CIP is the first application for the invention of the new matter according to Article 87(1) EPC. 

  1. CIP New Matter Is an Example Wholly Encompassed by the Parent Application

Where the CIP's new matter does not add a new element to the invention covered by the parent application, the parent application remains the "first application" disclosing the invention claimed in the European application.  As such, the parent application alone supports a valid priority claim. 

A priority claim to the CIP may be valid, however, if a dependent claim in the European application cannot be derived from the parent application alone.    

  1. European Application Claims Read on Subject Matter of Parent Application

As in scenario 2, a European application cannot validly claim priority to a CIP when the European claims read on the subject matter of the parent application.  The "first application" to disclose what the European application claims recite is the parent application. 

These three scenarios are particularly relevant where the parent application was filed more than twelve months before the European application.  Outside of this priority period, and when the European application's claims are not entitled to the CIP's priority date, the claims take the filing date of the European application.  Any disclosures made before the European application's filing date can be used to attack the validity of the claims, including disclosures made by the applicant and publication of the parent application.  A parent application published after the filing date of the European application by the EPO or as a PCT application may still qualify as prior art for novelty purposes under Article 54(3) EPC. 

Under these circumstances, practitioners may avoid risking the validity of a European application due to an invalid priority claim to a CIP by only reciting claims that are exclusively based on the CIP application.

Amendments During Examination

Even after ensuring that a European application as filed contains a valid priority claim, applicants risk losing the claimed priority during prosecution through claim amendments.  To maintain the claimed priority, practitioners should consider the content of the priority application and attempt to introduce amendments that are clearly and unambiguously supported in the priority application. 


The EPO's strict priority standard means that practitioners must pay close attention to the preparation of the priority application so it can adequately support potential claims that may be envisaged.  Failure to secure proper priority may leave an application vulnerable to the applicant's own disclosures.


1 Where an application is filed under the Patent Cooperation Treaty (PCT), the PCT filing date is taken as the filing date under the EPC and not the date of entry into the European regional phase.

2 Enlarged Board of Appeal in G2/98, [2001] OJ EPO 413, 433.

3 Art. 88(4) EPC (recognizing priority claims to any matter disclosed in the priority application, not just to the claims of a priority application); Guidelines for Examination F.VI, 2.2.

4 Guidelines for Examination F.VI, 2.2.

5 Id. at F.VI, 2.4.4.

6 See id.; id. at F.VI, 1.4.1.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
17 Nov 2018, Conference, Washington, DC, United States

Finnegan partner Clare Cornell will present “Covert Trademark Use in the Internet: Licit or Illicit” at the Asian Patent Attorneys Association Conference.

20 Nov 2018, Webinar, Washington, DC, United States

As part of Strafford Publications’ webinar series, Finnegan attorneys Tom Irving, Josh Goldberg, and Cory Bell will analyze Patent Trial and Appeal Board denials and partial denials, offering take-home lessons applicable in

21 Nov 2018, Workshop, London, UK

Finnegan partner Leythem Wall will consider European claim drafting strategy and lead the Chemical Workshop during a two-day course, hosted by Management Forum.

Similar Articles
Relevancy Powered by MondaqAI
Foley & Lardner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Foley & Lardner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions